Loading...
GNFT logo

Genfit S.A.ENXTPA:GNFT Stock Report

Market Cap €588.3m
Share Price
n/a
1Y234.6%
7D-2.4%
1D2.0%
Portfolio Value
​
View

Genfit S.A.

ENXTPA:GNFT Stock Report

Market Cap: €588.3m

Genfit (GNFT) Stock Overview

Engages in the research and development of medicines and diagnostic solutions in France and internationally. More details

GNFT fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Rewards

Trading at 80.4% below our estimate of its fair value

Earnings are forecast to grow 58.85% per year

Risk Analysis

Negative shareholders equity

Highly volatile share price over the past 3 months compared to the French market


GNFT Community Fair Values

Create Narrative

See what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW446,702 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
446,702 investors already sharing narratives
View all narratives

Genfit S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genfit
Historical stock prices
Current Share Price€12.00
52 Week High€15.48
52 Week Low€3.05
Beta1.13
1 Month Change-13.54%
3 Month Change15.61%
1 Year Change234.63%
3 Year Change242.37%
5 Year Change265.19%
Change since IPO-7.41%

Recent News & Updates

Recent updates

Analysis Article • Sep 23

These Analysts Just Made An Downgrade To Their Genfit S.A. (EPA:GNFT) EPS Forecasts

The analysts covering Genfit S.A. ( EPA:GNFT ) delivered a dose of negativity to shareholders today, by making a...
Analysis Article • Jul 16

Some Analysts Just Cut Their Genfit S.A. (EPA:GNFT) Estimates

The latest analyst coverage could presage a bad day for Genfit S.A. ( EPA:GNFT ), with the analysts making...
Analysis Article • Jun 11

Shareholders Will Probably Not Have Any Issues With Genfit S.A.'s (EPA:GNFT) CEO Compensation

Key Insights Genfit's Annual General Meeting to take place on 17th of June Salary of €405.6k is part of CEO M...
Analysis Article • May 06

Improved Revenues Required Before Genfit S.A. (EPA:GNFT) Stock's 29% Jump Looks Justified

Genfit S.A. ( EPA:GNFT ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Taking...
Analysis Article • May 02

Solid Earnings Reflect Genfit's (EPA:GNFT) Strength As A Business

When companies post strong earnings, the stock generally performs well, just like Genfit S.A.'s ( EPA:GNFT ) stock has...
Analysis Article • Apr 29

These 4 Measures Indicate That Genfit (EPA:GNFT) Is Using Debt Reasonably Well

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Nov 16

Genfit S.A. (EPA:GNFT) Not Doing Enough For Some Investors As Its Shares Slump 25%

The Genfit S.A. ( EPA:GNFT ) share price has softened a substantial 25% over the previous 30 days, handing back much of...
Analysis Article • Sep 27

We Think Shareholders Should Be Aware Of Some Factors Beyond Genfit's (EPA:GNFT) Profit

After announcing healthy earnings, Genfit S.A.'s ( EPA:GNFT ) stock rose over the last week. Despite the strong profit...
Analysis Article • Sep 26

Genfit S.A. (EPA:GNFT) Held Back By Insufficient Growth Even After Shares Climb 26%

Genfit S.A. ( EPA:GNFT ) shares have continued their recent momentum with a 26% gain in the last month alone. Looking...
Analysis Article • Sep 24

Growth Investors: Industry Analysts Just Upgraded Their Genfit S.A. (EPA:GNFT) Revenue Forecasts By 28%

Celebrations may be in order for Genfit S.A. ( EPA:GNFT ) shareholders, with the analysts delivering a significant...
Analysis Article • Sep 22

Genfit (EPA:GNFT) Seems To Use Debt Quite Sensibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • May 23

Genfit S.A.'s (EPA:GNFT) Price Is Right But Growth Is Lacking After Shares Rocket 28%

The Genfit S.A. ( EPA:GNFT ) share price has done very well over the last month, posting an excellent gain of 28...
Analysis Article • Jan 03

Genfit S.A.'s (EPA:GNFT) 26% Price Boost Is Out Of Tune With Revenues

Genfit S.A. ( EPA:GNFT ) shareholders have had their patience rewarded with a 26% share price jump in the last month...
Analysis Article • Sep 22

Health Check: How Prudently Does Genfit (EPA:GNFT) Use Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Jul 05

Revenue Downgrade: Here's What Analysts Forecast For Genfit S.A. (EPA:GNFT)

Today is shaping up negative for Genfit S.A. ( EPA:GNFT ) shareholders, with the analysts delivering a substantial...
Analysis Article • Jun 23

Genfit S.A. (EPA:GNFT) Investors Are Less Pessimistic Than Expected

Genfit S.A.'s ( EPA:GNFT ) price-to-sales (or "P/S") ratio of 7.1x might make it look like a strong sell right now...
Analysis Article • Dec 28

We Think Genfit (EPA:GNFT) Can Manage Its Debt With Ease

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Sep 30

New Forecasts: Here's What Analysts Think The Future Holds For Genfit S.A. (EPA:GNFT)

Genfit S.A. ( EPA:GNFT ) shareholders will have a reason to smile today, with the analysts making substantial upgrades...
Analysis Article • Jun 29

Downgrade: Here's How Analysts See Genfit S.A. (EPA:GNFT) Performing In The Near Term

The latest analyst coverage could presage a bad day for Genfit S.A. ( EPA:GNFT ), with the analysts making...
Analysis Article • Mar 14

Genfit's(EPA:GNFT) Share Price Is Down 85% Over The Past Five Years.

Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Imagine if you held...

Shareholder Returns

GNFTFR BiotechsFR Market
7D-2.4%-9.3%-2.6%
1Y234.6%12.3%-1.7%

Return vs Industry: GNFT exceeded the French Biotechs industry which returned 12.3% over the past year.

Return vs Market: GNFT exceeded the French Market which returned -1.7% over the past year.

Price Volatility

Is GNFT's price volatile compared to industry and market?
GNFT volatility
GNFT Average Weekly Movement10.3%
Biotechs Industry Average Movement7.0%
Market Average Movement4.2%
10% most volatile stocks in FR Market8.8%
10% least volatile stocks in FR Market2.1%

Stable Share Price: GNFT's share price has been volatile over the past 3 months compared to the French market.

Volatility Over Time: GNFT's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.

About the Company

FoundedEmployeesCEOWebsite
1999161M. Prigentwww.genfit.com

Genfit S.A., together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally. The company offers elafibranor for the treatment of primary biliary cholangitis; and NIS, a non-invasive diagnostic technology for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops elafibranor, which is in Phase 3 clinical trial for the treatment of primary sclerosing cholangitis; GNS561, which is in Phase 1b clinical trial for the treatment of cholangiocarcinoma; and G1090N/NTZ, which is in Phase 1 clinical trial for the treatment of acute-on-chronic liver failure continuum.

Genfit S.A. Fundamentals Summary

How do Genfit's earnings and revenue compare to its market cap?
GNFT fundamental statistics
Market cap€588.28m
Earnings (TTM)-€85.97m
Revenue (TTM)€70.85m
8.5x
P/S Ratio
-7.0x
P/E Ratio

Is GNFT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GNFT income statement (TTM)
Revenue€70.85m
Cost of Revenue€0
Gross Profit€70.85m
Other Expenses€156.81m
Earnings-€85.97m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Sep 29, 2026

Earnings per share (EPS)-1.72
Gross Margin100.00%
Net Profit Margin-121.35%
Debt/Equity Ratio-651.3%

How did GNFT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/16 17:27
End of Day Share Price 2026/09/16 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genfit S.A. is covered by 14 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geoffrey MeachamBofA Global Research
Arnaud CadartCIC Market Solutions (ESN)
Alethia YoungDeutsche Bank